Inceptive is a data-driven lab focused on AI medicines, creating tools for the rational design of novel biomolecules and biological software. The company has offices in Palo Alto, Berlin, and Zurich, and is pioneering the next generation of AI-driven medical advancements.
Subscribe to see Inceptive’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Inceptive is a biotech company headquartered in Palo Alto, United States. It has raised at least $120M across the 2 funding rounds on record. Its most recent funding round, Series A, raised $100M in November 2023. Xcout recorded 15 job postings from Inceptive in the last 90 days, naming tools such as Palo Alto Networks, PyTorch.
At least $120M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $100M | 5 named | |
| — | $20M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 15 job postings from Inceptive in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Inceptive's hiring signals →
A few of Inceptive's closest competitors — see the full list of competitors and alternatives →
Pepticom operates an artificial intelligence-driven drug discovery platform focused on designing and optimizing novel therapeutic peptides. The company utilizes reinforcement learning, generative AI, and computational algorithms to develop drug candidates for both internal programs and industry collaborations.
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Syntekabio Inc. is a South Korean bioinformatics venture firm founded in 2009. The company operates as an artificial intelligence new drug development company, utilizing genomic big data.
DenovAI Biotech Ltd is an Israeli biotechnology startup founded in 2023 and operated through the AION Labs venture studio in Rehovot. The company develops a generative AI and physics platform focused on the de novo design of novel proteins and therapeutic biologics.
B12 Labs provides an AI-powered software platform that automates and accelerates chemical synthesis for the pharmaceutical and biotechnology industries. Its tools assist researchers with retrosynthesis planning, reaction condition optimization, and the generation of execution-ready protocols for lab automation equipment.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Inceptive? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.